CLIA Kit for Angiotensinogen (AGT)

ANHU; SERPINA8; Angiotensin; Renin Substrate; Serpin Peptidase Inhibitor,Clade A,Member 8(Alpha-1 Antiproteinase,Antitrypsin)

  • CLIA Kit for Angiotensinogen (AGT) Packages (Simulation)
  • CLIA Kit for Angiotensinogen (AGT) Packages (Simulation)
  • CLIA Kit for Angiotensinogen (AGT) Results demonstration
  • SCA797Mu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Angiotensinogen (AGT)

This assay has high sensitivity and excellent specificity for detection of Angiotensinogen (AGT).
No significant cross-reactivity or interference between Angiotensinogen (AGT) and analogues was observed.

Recovery of the CLIA Kit for Angiotensinogen (AGT)

Matrices listed below were spiked with certain level of recombinant Angiotensinogen (AGT) and the recovery rates were calculated by comparing the measured value to the expected amount of Angiotensinogen (AGT) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-89 86
EDTA plasma(n=5) 79-97 87
heparin plasma(n=5) 88-102 96

Precision of the CLIA Kit for Angiotensinogen (AGT)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Angiotensinogen (AGT) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Angiotensinogen (AGT) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Angiotensinogen (AGT)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Angiotensinogen (AGT) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 80-104% 95-102% 87-95% 86-101%
EDTA plasma(n=5) 81-101% 78-101% 92-99% 99-105%
heparin plasma(n=5) 95-103% 85-99% 85-94% 95-105%

Stability of the CLIA Kit for Angiotensinogen (AGT)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Angiotensinogen (AGT)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Angiotensinogen (AGT)

The microplate provided in this kit has been pre-coated with an antibody specific to Angiotensinogen (AGT). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Angiotensinogen (AGT). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Angiotensinogen (AGT) level in the sample or standard.;

Related products

Catalog No. Organism species: Mus musculus (Mouse) Applications (RESEARCH USE ONLY!)
EPA797Mu61 Eukaryotic Angiotensinogen (AGT) Positive Control; Immunogen; SDS-PAGE; WB.
RPA797Mu01 Recombinant Angiotensinogen (AGT) Positive Control; Immunogen; SDS-PAGE; WB.
APA797Mu61 Active Angiotensinogen (AGT) Cell culture; Activity Assays.
RPA797Mu02 Recombinant Angiotensinogen (AGT) Positive Control; Immunogen; SDS-PAGE; WB.
PAA797Mu01 Polyclonal Antibody to Angiotensinogen (AGT) WB; IHC; ICC; IP.
PAA797Mu02 Polyclonal Antibody to Angiotensinogen (AGT) WB; IHC; ICC; IP.
LAA797Mu81 FITC-Linked Polyclonal Antibody to Angiotensinogen (AGT) WB; IHC; ICC; IF.
LAA797Mu71 Biotin-Linked Polyclonal Antibody to Angiotensinogen (AGT) WB; IHC; ICC.
SEA797Mu ELISA Kit for Angiotensinogen (AGT) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA797Mu CLIA Kit for Angiotensinogen (AGT) Chemiluminescent immunoassay for Antigen Detection.
LMA797Mu Multiplex Assay Kit for Angiotensinogen (AGT) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK